ISRG · 8-K · 20261020PR000067

Guidance / Outlook

INTUITIVE SURGICAL INC · 2026-10-20 · Importance 63 · Surprise 60 · No source text

For full-year 2026, Intuitive expects worldwide da Vinci procedure growth of approximately 14% to 15%, with growth expected near the midpoint of the range. Management forecasts non-GAAP gross profit margin of 68.7% to 69.3% of revenue, including an estimated 0.9% of revenue impact from currently effective tariffs and excluding recognized tariff refunds. Non-GAAP operating expense growth is expected to be 11% to 13%. The margin outlook assumes current tariffs remain in effect through year-end, and additional tariffs could materially change the company’s financial results and expected margin.

Key facts

• The Company expects non-GAAP operating expense growth of 11% to 13% in 2026. source
• The Company expects non-GAAP gross profit margin to be within a range of 68.7% to 69.3% of revenue in 2026, and this range includes an estimated impact from tariffs of 0.9% of revenue (excluding recognized tariff refunds). source
• The Company expects worldwide da Vinci procedure growth of approximately 14% to 15% in 2026 and expects to be closer to the midpoint of this range. source
• The Company disclosed forward-looking estimates including expected non-GAAP gross profit margins and operating expense growth but said it does not provide a reconciliation of non-GAAP outlook measures to GAAP because it cannot predict the timing and outcome of items such as legal proceedings. source
• The Company will hold a teleconference at 1:30 p.m. PDT on October 20, 2026 to discuss the third quarter 2026 financial results, with a live webcast accessible on the Company website. source

Impact estimates